Target intelligence / Profile preview

Ro60-associated Y4 RNA (RNY4)

Target
RNY4
Molecular classification
Noncoding RNA, Small cytoplasmic RNA, Y RNA family
01

Overview

Ro60-associated Y4 RNA (RNY4) is a small, highly structured, noncoding RNA of the Y RNA family that forms part of the Ro60 ribonucleoprotein (RNP) particle[1][2][3]. It is found predominantly in animal cells and is known for binding to the Ro60 autoantigen protein, which is a ring-shaped RNA-binding protein. RNY4 regulates the subcellular localization and accumulation of Ro60[2], modulates RNA surveillance by controlling access of other RNAs to Ro60, and participates in specialized ribonucleoprotein complexes by tethering Ro60 to other effector proteins[1][2]. Beyond its role as a Ro60 ligand and modulator, RNY4 (like other Y RNAs) is *functionally required for the initiation of chromosomal DNA replication* in vertebrate cells[3]. RNY4 (and other Y RNAs) are also of clinical significance as autoantigenic targets in systemic autoimmune diseases such as systemic lupus erythematosus and Sjögren’s syndrome, and are overexpressed in some human tumors[1][3]. RNY4 is not itself a druggable therapeutic target (such as a receptor or enzyme) but rather a regulatory noncoding RNA essential for cellular homeostasis and with links to disease pathology.

Other names
hY4HY4Y4RNA, Ro-associated Y4RNA, Y4 small cytoplasmic (associated with Ro protein)RNY4
02

Biological functions

Regulation of Ro60 protein localization and stabilityInitiation of DNA replicationQuality control in RNA metabolism (via effects on Ro60)
03

Disease associations

Autoimmunity (implicated in diseases such as systemic lupus erythematosus and Sjögren’s syndrome)Cancer (Y RNAs are overexpressed in some tumors)

Beyond the preview

Go deeper on Ro60-associated Y4 RNA (RNY4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ro60-associated Y4 RNA (RNY4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call